Location History:
- Vienna, AU (2012)
- Vienna, AT (2012 - 2014)
Company Filing History:
Years Active: 2012-2014
Title: The Innovative Ventures of Oliver Kraemer in Vienna
Introduction: Oliver Kraemer, a brilliant inventor based in Vienna, has made significant contributions to the field of pharmaceuticals with a total of 6 patents under his name. His cutting-edge research and inventions have paved the way for advancements in treating diseases characterized by abnormal cell proliferation.
Latest Patents:
1. 5-alkynyl-pyrimidines: Kraemer's invention includes compounds that are effective in treating diseases characterized by excessive cell proliferation. These compounds, represented by Formula (1), have shown promise in developing medications with targeted therapeutic properties.
2. 5-alkynyl-pyridines: Another groundbreaking patent by Kraemer involves the use of 5-alkynyl-pyridines as inhibitors of PI3Kalpha activity. These compounds, defined by Formula (I), have demonstrated potential in the treatment and prevention of conditions such as cancer associated with abnormal cell proliferation.
Career Highlights: Oliver Kraemer is currently affiliated with Boehringer Ingelheim International GmbH, where he continues to drive innovation in the pharmaceutical industry. His expertise and dedication to research have positioned him as a leading figure in the development of novel therapeutic solutions.
Collaborations: Kraemer has collaborated with esteemed professionals in his field, including Tobias Wunberg and Ulrich Reiser. Together, they have worked on cutting-edge projects that have the potential to revolutionize the way diseases are treated.
Conclusion: Oliver Kraemer's remarkable journey as an inventor showcases his commitment to advancing healthcare through innovation. His patents and collaborations exemplify his relentless pursuit of scientific excellence, making him a standout figure in the realm of pharmaceutical inventions.